Table 1

Clinical and biochemical characteristics in NAFLD patients and controls subjects
PATIENTS (n=35) CONTROLS (n=51) P
Total Cholesterol 187.91 ± 38.83 182.27 ± 38.36 0.516
HDL 44.30 ± 13.83 53.51 ± 15.27 0.006*
LDL 115.49 ± 35.88 110.46 ± 32.38 0.509
Triglycerides 171.72 ± 80.91 93.77 ± 39.70 p< 0.001*
Fasting Glucose 99.67 ± 35.59 92.09 ± 10.50 0.167
Insulin 16.55 ± 10.74 7.12 ± 4.22 p < 0.001*
HOMA value >3.0 3.90 ± 2.75 1.65 ± 1.10 p < 0.001*
AST 54.51 ± 31.94 18.20 ± 5.93 p< 0.001*
ALT 82.15 ± 38.72 14.82 ± 8.99 p < 0.001*
GGT 126.38 ± 125.90 28.35 ± 22.61 p< 0.001*
AP 87.15 ± 53.88 63.92 ± 33.53 0.019*
BMI 29.77 ± 4.38 24.22 ± 3.68 p < 0.001*

* t-Test was applied for these groups specifically. BMI. body mass index; HDL-C. high-density-lipoprotein cholesterol; LDL-C. Low-density- lipoprotein cholesterol.

de Carvalho et al.

de Carvalho et al. Nutrition Journal 2013 12:37   doi:10.1186/1475-2891-12-37

Open Data